• Info
  • Insider Ownership

Insider Trading & Ownership of Ron Squarer

Location
San Diego, CA
Summary
The estimated net worth of Ron Squarer is at least $1,223,787 dollars as of 11 Dec 2025. Ron Squarer is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $648,423. Ron Squarer is the Director of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $335,184. Ron Squarer is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $240,180.
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Ron Squarer files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Ron Squarer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $648,423 15 May 2025
ADCT ADC Therapeutics SA Director $335,184 13 Jun 2025
NUVL Nuvalent, Inc. Director $240,180 10 Dec 2025
NA Deciphera Pharmaceuticals, Inc. Director $0 11 Jun 2024

Insider Transactions Reported by Ron Squarer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.